-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
BriaCell Therapeutics Corp. quarterly and annual General and Administrative Expense history and change rate from 2021 to Q2 2025.
- BriaCell Therapeutics Corp. General and Administrative Expense for the quarter ending 31 Jul 2025 was $1,443,909, a 5.98% increase year-over-year.
- BriaCell Therapeutics Corp. General and Administrative Expense for the twelve months ending 31 Jul 2025 was $5,934,125, a 3.55% decline year-over-year.
- BriaCell Therapeutics Corp. annual General and Administrative Expense for 2025 was $5,934,125, a 3.55% decline from 2024.
- BriaCell Therapeutics Corp. annual General and Administrative Expense for 2024 was $6,152,269, a 22.5% decline from 2023.
- BriaCell Therapeutics Corp. annual General and Administrative Expense for 2023 was $7,935,626, a 9.19% increase from 2022.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Change (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Change (%)